SCHEMBL6404885

SCHEMBL6404885

COc1ccc(-c2nnc(SCc3ccccc3)n2-c2ccccc2)cc1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.72
ALDH1A1 P00352 2/20 0.72
NPC1 O15118 1/20 0.72
RAB9A P51151 1/20 0.72
HPGD P15428 4/20 0.71
NPSR1 Q6W5P4 4/20 0.71
SMN1; SMN2 Q16637 5/20 0.70
GAA P10253 1/20 0.70
MAPK1 P28482 1/20 0.70
MEN1 O00255 4/20 0.68
KMT2A Q03164 4/20 0.68
LMNA P02545 4/20 0.66
USP2 O75604 2/20 0.66
HTT P42858 2/20 0.66
TP53 P04637 2/20 0.62
METAP2 P50579 2/20 0.62
TNKS2 Q9H2K2 1/20 0.62
CYP3A4 P08684 2/20 0.60
CYP2C9 P11712 2/20 0.60
CYP1A2 P05177 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6403463 0.91 CYP3A4 (0.73) TSHRALDH1A1NPC1RAB9AHPGD
SCHEMBL6406121 0.89 SMN1; SMN2 (0.65) TSHRALDH1A1NPC1RAB9AHPGD
SCHEMBL14426679 0.87 SMN1; SMN2 (0.92) TSHRALDH1A1NPC1RAB9AHPGD
SCHEMBL28375277 0.85 SMN1; SMN2 (0.62) TSHRALDH1A1NPC1RAB9AHPGD
SCHEMBL27952226 0.85 MAPK1 (0.71) TSHRALDH1A1NPC1RAB9AHPGD
SCHEMBL4206785 0.85 RAB9A (0.75) TSHRALDH1A1NPC1RAB9AHPGD
SCHEMBL31411197 0.84 SMN1; SMN2 (0.63) TSHRALDH1A1NPC1RAB9AHPGD
SCHEMBL6405572 0.84 HPGD (0.73) TSHRALDH1A1HPGDNPSR1SMN1; SMN2
SCHEMBL6406205 0.83 MEN1 (0.71) TSHRALDH1A1HPGDNPSR1SMN1; SMN2
SCHEMBL6251016 0.83 ALDH1A1 (0.67) TSHRALDH1A1HPGDNPSR1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050288347-A1 Certain triazole-based compounds, compositions, and uses thereof AGRIUS GROUP, LLC. 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288347-A1 Certain triazole-based compounds, compositions, and uses thereof ABCG2, ATP5ME, DNTT TSHR 3470/4885ALDH1A1 720/4885NPC1 2070/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.